Monash Antibody Technology Facility

The Monoclonal Antibody Technology Facility (MATF) was established to provide national and international Life Science researchers custom-made, high-affinity monoclonal antibodies and support services.

The MATF seeks to be the highest throughput monoclonal antibody development facility in the world and will build on its current proprietary technology to generate powerful new assays for discovery research and drug development. It also offers a unique and powerful ability to comprehensively characterise activated proteins and protein complexes.